These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Conesa-Botella A, Meintjes G, Coussens AK, van der Plas H, Goliath R, Schutz C, Moreno-Reyes R, Mehta M, Martineau AR, Wilkinson RJ, Colebunders R, Wilkinson KA. Clin Infect Dis; 2012 Oct; 55(7):1004-11. PubMed ID: 22715179 [Abstract] [Full Text] [Related]
3. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. Conesa-Botella A, Loembé MM, Manabe YC, Worodria W, Mazakpwe D, Luzinda K, Mayanja-Kizza H, Miri M, Mbabazi O, Koole O, Kestens L, Colebunders R, TB IRIS Group. J Acquir Immune Defic Syndr; 2011 Dec 15; 58(5):463-8. PubMed ID: 21963941 [Abstract] [Full Text] [Related]
4. Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients. Breton G, Bourgarit A, Pavy S, Bonnet D, Martinez V, Duval X, Longuet P, Abgrall S, Simon A, Leport C, Paradox-TB Study Group. Int J Tuberc Lung Dis; 2012 Oct 15; 16(10):1365-70. PubMed ID: 23107635 [Abstract] [Full Text] [Related]
5. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection. Worodria W, Menten J, Massinga-Loembe M, Mazakpwe D, Bagenda D, Koole O, Mayanja-Kizza H, Kestens L, Mugerwa R, Reiss P, Colebunders R, TB-IRIS Study Group. Antivir Ther; 2012 Oct 15; 17(5):841-8. PubMed ID: 22543224 [Abstract] [Full Text] [Related]
6. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, Menten J, Van Leth F, Mayanja-Kizza H, Kestens L, Mugerwa RD, Reiss P, Colebunders R, TB-IRIS Study Group. J Acquir Immune Defic Syndr; 2011 Sep 01; 58(1):32-7. PubMed ID: 21654499 [Abstract] [Full Text] [Related]
7. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A, Manabe YC, Kestens L, Colebunders R. Clin Dev Immunol; 2011 Sep 01; 2011():758350. PubMed ID: 21197091 [Abstract] [Full Text] [Related]
8. Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China. Xue M, Xie R, Pang Y, Yan S, Du Y, Guan C, Chen B. BMC Infect Dis; 2020 Jul 31; 20(1):554. PubMed ID: 32736608 [Abstract] [Full Text] [Related]
9. Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. Goovaerts O, Jennes W, Massinga-Loembé M, Ondoa P, Ceulemans A, Vereecken C, Worodria W, Mayanja-Kizza H, Colebunders R, Kestens L, TB-IRIS Study Group. PLoS One; 2015 Jul 31; 10(7):e0133924. PubMed ID: 26208109 [Abstract] [Full Text] [Related]
10. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. Ravimohan S, Tamuhla N, Nfanyana K, Steenhoff AP, Letlhogile R, Frank I, MacGregor RR, Gross R, Weissman D, Bisson GP. Clin Infect Dis; 2016 Mar 15; 62(6):795-803. PubMed ID: 26611774 [Abstract] [Full Text] [Related]
11. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Prak N, Kim C, Dim B, Nerrienet E, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX, CAMELIA (ANRS 1295 – CIPRA KH001) Study Team. AIDS; 2013 Oct 23; 27(16):2577-86. PubMed ID: 24096631 [Abstract] [Full Text] [Related]
12. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in initiating ART among HIV-Infected patients in China-risk factors and management. Yang H, Liu Q, Wu Y, He K, Zeng Q, Liu M. BMC Infect Dis; 2024 Jan 02; 24(1):5. PubMed ID: 38166781 [Abstract] [Full Text] [Related]
13. Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes. Sloan DJ, Mwandumba HC, Kamdolozi M, Shani D, Chisale B, Dutton J, Khoo SH, Allain TJ, Davies GR. Int J Tuberc Lung Dis; 2015 Aug 02; 19(8):904-11. PubMed ID: 26162355 [Abstract] [Full Text] [Related]
14. Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study. Musarurwa C, Zijenah LS, Mhandire DZ, Bandason T, Mhandire K, Chipiti MM, Munjoma MW, Mujaji WB. BMC Pulm Med; 2018 May 08; 18(1):67. PubMed ID: 29739378 [Abstract] [Full Text] [Related]
15. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S. J Infect; 2006 Dec 08; 53(6):357-63. PubMed ID: 16487593 [Abstract] [Full Text] [Related]
16. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study. Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Nfanyana K, Bellamy SL, MacGregor RR, Gross R, Weissman D, Bisson GP. Lancet Infect Dis; 2015 Apr 08; 15(4):429-38. PubMed ID: 25672566 [Abstract] [Full Text] [Related]
17. Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome. Tran HT, Van den Bergh R, Loembé MM, Worodria W, Mayanja-Kizza H, Colebunders R, Mascart F, Stordeur P, Kestens L, De Baetselier P, Raes G, TB-IRIS study group. AIDS; 2013 Jul 17; 27(11):1725-34. PubMed ID: 23807270 [Abstract] [Full Text] [Related]
18. Antigen-specific interferon-gamma responses and innate cytokine balance in TB-IRIS. Goovaerts O, Jennes W, Massinga-Loembé M, Ceulemans A, Worodria W, Mayanja-Kizza H, Colebunders R, Kestens L, TB-IRIS Study Group. PLoS One; 2014 Jul 17; 9(11):e113101. PubMed ID: 25415590 [Abstract] [Full Text] [Related]
19. Vitamin D deficiency and risk of postpartum tuberculosis among HIV-infected breastfeeding mothers in India. Mave V, Chandanwale A, Bhosale R, Shere D, Gupte N, Suryavanshi N, Kulkarni V, Kagal A, Bharadwaj R, Joshi S, Bollinger RC, Gupta A, SWEN (Six Weeks Extended Nevirapine India) and Byramjee-Jeejeebhoy Medical College Clinical Trials Unit Study team. Int J Tuberc Lung Dis; 2015 Mar 17; 19(3):302-4. PubMed ID: 25686138 [Abstract] [Full Text] [Related]
20. Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with Mycobacterium tuberculosis. Price P, Haddow LJ, Affandi J, Agarwal U, Easterbrook PJ, Elliott J, French M, Kumar M, Moosa MY, Oliver B, Singh S, Sola M, Saphonn V, Vun MC. AIDS Res Hum Retroviruses; 2012 Oct 17; 28(10):1216-9. PubMed ID: 22280097 [Abstract] [Full Text] [Related] Page: [Next] [New Search]